Cite
Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas.
MLA
Donmez, Gamze, et al. “Vascular Endothelial Growth Factor (VEGF), Matrix Metalloproteinase-9 (MMP-9), and Thrombospondin-1 (TSP-1) Expression in Urothelial Carcinomas.” Pathology, Research and Practice, vol. 205, no. 12, 2009, pp. 854–57. EBSCOhost, https://doi.org/10.1016/j.prp.2009.07.015.
APA
Donmez, G., Sullu, Y., Baris, S., Yildiz, L., Aydin, O., Karagoz, F., & Kandemir, B. (2009). Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas. Pathology, Research and Practice, 205(12), 854–857. https://doi.org/10.1016/j.prp.2009.07.015
Chicago
Donmez, Gamze, Yurdanur Sullu, Sancar Baris, Levent Yildiz, Oguz Aydin, Filiz Karagoz, and Bedri Kandemir. 2009. “Vascular Endothelial Growth Factor (VEGF), Matrix Metalloproteinase-9 (MMP-9), and Thrombospondin-1 (TSP-1) Expression in Urothelial Carcinomas.” Pathology, Research and Practice 205 (12): 854–57. doi:10.1016/j.prp.2009.07.015.